SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XILLIX FDA APPROVED

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: hsg who wrote (433)7/16/1999 1:37:00 PM
From: Edward W. Richmond  Read Replies (1) of 572
 
hsg, I don't see the products as the problem. The products, in my opinion are great. They enhance life-saving medicine. However, the marketing/distribution by Olympus, in my opinion, has been poor, not even meeting their promised goals. Therein lies my lack of confidence in XLX. Olympus seems to have a STRANGLE HOLD on all XLX products.
We can hope for improvement. I do expect a price rise prior to the AGM at which time I plan to unload. Some good news would change my mind. However, I expect more promises and future expectations, but little in tangible results.
Sure hope I am wrong.
Best regards, Ed
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext